Some studies reported a positive correlation between serum sclerostin level and subclinical atherosclerosis [3], atherosclerotic lesions [14, 30] and cardiovascular mortality [17] in T2D population regardless of sex and age. The gene discussed is SOST; the disease is atherosclerosis.